Attached files
EXHIBIT 99.1
NEWS
----
EQNX
Equinox International Inc.
3300 S. Decatur, #10542, Las Vegas, NV 89102 (267) 295-7814
Contact: Robert T. Yurckonis
Chief Executive Officer
941-780-2362
E-mail: tyler812@comcast.net
For Immediate Release Monday March 1, 2010
Equinox International to Acquire Innovative Medical Technology
LAS VEGAS, March 1, 2010 (GLOBE NEWSWIRE) - Equinox International
(OTCBB: EQNX) (the "Company") has entered into a binding agreement to
acquire certain exclusive technology rights of Biostem US L.L.C., a Florida
medical technology company, for a controlling interest in stock of the
Company. The transaction has received stockholder approval and will close as
soon as all regulatory requirements have been satisfied. Said Tyler
Yurckonis, the Company's CEO, "This transaction represents an opportunity for
us to create significant value for our shareholders, and we are extremely
excited about the prospects for Biostem technology and methods the Company
will soon introduce to the medical marketplace."
About the Company
EQNX is a development stage company with non-operating interests in two
producing oil and gas wells in Alberta, Canada that has been seeking to raise
capital to acquire additional interests in producing and development stage
oil and gas exploration wells with exploration potential.
About Biostem US L.L.C.
Founded earlier this year by researcher John Satino and Dr. Michael Markou,
of Clearwater, Florida, Biostem US L.L.C. has proprietary technology and
methods that represent a new and improved approach to treating hair loss, by
utilizing platelets derived from a patient's own stem cells, injected in the
scalp, to stimulate hair growth. It is expected that the Biostem technology
and methods to be acquired by the Company will be adopted by more than 15
hair loss clinics across the United States in the coming three months.
CONTACT: Equinox International
Robert T. Yurckonis, Chief Executive Officer
941-780-2362
tyler812@comcast.net
